NEW YORK (GenomeWeb) – DNA chip developer Centrillion Technologies said today that it has received a multimillion US dollar investment from medical and healthcare solutions firm WeDoctor of China as part of a strategic partnership. Separately, Centrillion Technologies Taiwan said it has received a strategic investment of an undisclosed amount from the Arm IoT Fund.

Palo Alto, California-based Centrillion also recently raised at least $56 million in private placements, according to documents filed  with the US Securities and Exchange Commission last month.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.